Multi-Color Corp. (NASDAQ:LABL) reported fiscal third-quarter profit of $9.5 million. The Batavia, Ohio-based company said it had profit of 57 cents per share. Earnings, adjusted for pretax expenses and non-recurring costs, were 73 cents per share. On Monday shares of Multi-Color Corp. (NASDAQ:LABL) closed at $61.15. Company’s sales growth for last 5 years was 19.50% and EPS growth for next 5 years is recorded as 13.50%.
On 4 February, Westell Technologies, Inc. (NASDAQ: WSTL), announced results for its fiscal 2015 third quarter ended December 31, 2014. Consolidated revenue was $14.0 million, consisting of $5.4 million from the In-Building Wireless (IBW) segment and $8.6 million from the Communication Solutions Group (CSG) segment. Westell Technologies, Inc. (NASDAQ:WSTL) in last trading activity increased 14.29% to close at $1.44. Company weekly performance is 4.35% while its quarterly performance stands at 2.13%. Westell Technologies, Inc. (NASDAQ:WSTL) is -69.56% away from its 52 week high.
On last trading day Plexus Corp. (NASDAQ:PLXS) increased 0.58% to close at $39.58. Its volatility for the week is 2.09% while volatility for the month is 2.69%. PLXS’s sales growth for past 5 years was 8.00% and its EPS growth for past 5 years was 16.60%. Plexus Corp. (NASDAQ:PLXS) monthly performance is -1.07%.
On 11 February, Discover Financial Services (NYSE:DFS) Fixed Rate Non-Cumulative Perpetual Preferred Stock, Series B will trade ex-dividend, for its quarterly dividend of $0.4062, payable on 2 march, 2015. Discover Financial Services (NYSE:DFS) has 1.10% insider ownership while its institutional ownership stands at 87.80%. In last trading activity company’s stock closed at $58.70.
GlaxoSmithKline (NYSE:GSK) announced that it has submitted another marketing application for Revolade in the EU. The company is looking to get the drug approved for the treatment of pediatric patients (aged 1 year and above) suffering from chronic immune (idiopathic) thrombocytopenic purpura (ITP) who have insufficiently responded to corticosteroids or immunoglobulins. On last trading day GlaxoSmithKline plc (NYSE:GSK) increased 0.85% to close at $46.39. Its volatility for the week is 1.24% while volatility for the month is 1.30%. GSK’s sales growth for past 5 years was 1.70% and its EPS growth for past 5 years was 4.60%. GlaxoSmithKline plc (NYSE:GSK) monthly performance is 7.41%.